Vimarsana
Biggest News Aggregation in the World

Page 2 - Left Ventricular Dysfunction News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Left Ventricular Dysfunction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Left Ventricular Dysfunction Today - Breaking & Trending Today

Study Reveals Racial Disparities in Advanced HF Therapies - Vimarsana News

Study Reveals Racial Disparities in Advanced HF Therapies

White adults were twice as likely as Black adults to receive a ventricular assist device or heart transplant.

PARADISE-MI Obscured As Post Hoc Analysis Finds Flaws - Vimarsana News

PARADISE-MI Obscured As Post Hoc Analysis Finds Flaws

A post-hoc analysis of the PARADISE-MI trial suggests relevant benefits are being missed in current trial design.

Medtronic Recalls Additional Faulty HeartWare HVAD Batteries - Vimarsana News

Medtronic Recalls Additional Faulty HeartWare HVAD Batteries

The latest recall for the company's HeartWare HVAD System involves defective batteries that could unexpectedly fail due to an electrical fault.

Blood Cell Biomarker May Predict Anthracycline LV Dysfunction - Vimarsana News

Blood Cell Biomarker May Predict Anthracycline LV Dysfunction

Monitoring of neutrophil-to-lymphocyte ratio could potentially help risk-stratify women on anthracycline chemotherapy for associated left-ventricular dysfunction, a prospective study suggests.

Myosin Inhibitor May Help Data-Deprived HF Patients With Low BP - Vimarsana News

Myosin Inhibitor May Help Data-Deprived HF Patients With Low BP

The novel agent most benefited those with low systolic BP, often excluded from major HF trials, but didn't help outcomes when baseline pressures were higher, post hoc analysis of GALACTIC-HF suggests.